Search research articles
Contact Us
Filters
Showing results (171-180 of 187) with videos related to
Page
of 19
Sort By:
Open Forum Infectious Diseases
|
February 10, 2022
Anatomical Site, Viral Ribonucleic Acid Abundance, and Time of Sampling Correlate With Molecular Detection of Severe Acute Respiratory Syndrome Coronavirus 2 During Infection
F Julian Lantry, Nusrat J Epsi, Simon D Pollett, et al.
Frontiers in Immunology
|
September 15, 2023
Natural killer cells and BNT162b2 mRNA vaccine reactogenicity and durability
Elizabeth K Graydon, Tonia L Conner, Kim Dunham, et al.
Science Translational Medicine
|
April 5, 2022
SARS-CoV-2 BA.1 variant is neutralized by vaccine booster-elicited serum but evades most convalescent serum and therapeutic antibodies
Sabrina Lusvarghi, Simon D Pollett, Sabari Nath Neerukonda, et al.
Biorxiv : the Preprint Server for Biology
|
January 4, 2022
SARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine booster
Sabrina Lusvarghi, Simon D Pollett, Sabari Nath Neerukonda, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 7, 2021
Adverse effects and antibody titers in response to the BNT162b2 mRNA COVID-19 vaccine in a prospective study of healthcare workers
Siâ Ana A Coggins, Eric D Laing, Cara H Olsen, et al.
Open Forum Infectious Diseases
|
December 15, 2021
COVID-19 Outcomes Among US Military Health System Beneficiaries Include Complications Across Multiple Organ Systems and Substantial Functional Impairment
Stephanie A Richard, Simon D Pollett, Charlotte A Lanteri, et al.
Open Forum Infectious Diseases
|
January 20, 2022
Adverse Effects and Antibody Titers in Response to the BNT162b2 mRNA COVID-19 Vaccine in a Prospective Study of Healthcare Workers
Si'Ana A Coggins, Eric D Laing, Cara H Olsen, et al.
The Journal of Infectious Diseases
|
October 21, 2021
Durability of SARS-CoV-2-Specific T-Cell Responses at 12 Months Postinfection
Zhongyan Lu, Eric D Laing, Jarina Pena DaMata, et al.
BMC Infectious Diseases
|
June 10, 2021
Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workers
Belinda M Jackson-Thompson, Emilie Goguet, Eric D Laing, et al.
Emerging Infectious Diseases
|
February 24, 2022
Novel Hendra Virus Variant Detected by Sentinel Surveillance of Horses in Australia
Edward J Annand, Bethany A Horsburgh, Kai Xu, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 187) with videos related to
Sort By:
Page
of 19
Open Forum Infectious Diseases
|
February 10, 2022
Anatomical Site, Viral Ribonucleic Acid Abundance, and Time of Sampling Correlate With Molecular Detection of Severe Acute Respiratory Syndrome Coronavirus 2 During Infection
F Julian Lantry, Nusrat J Epsi, Simon D Pollett, et al.
Frontiers in Immunology
|
September 15, 2023
Natural killer cells and BNT162b2 mRNA vaccine reactogenicity and durability
Elizabeth K Graydon, Tonia L Conner, Kim Dunham, et al.
Science Translational Medicine
|
April 5, 2022
SARS-CoV-2 BA.1 variant is neutralized by vaccine booster-elicited serum but evades most convalescent serum and therapeutic antibodies
Sabrina Lusvarghi, Simon D Pollett, Sabari Nath Neerukonda, et al.
Biorxiv : the Preprint Server for Biology
|
January 4, 2022
SARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine booster
Sabrina Lusvarghi, Simon D Pollett, Sabari Nath Neerukonda, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 7, 2021
Adverse effects and antibody titers in response to the BNT162b2 mRNA COVID-19 vaccine in a prospective study of healthcare workers
Siâ Ana A Coggins, Eric D Laing, Cara H Olsen, et al.
Open Forum Infectious Diseases
|
December 15, 2021
COVID-19 Outcomes Among US Military Health System Beneficiaries Include Complications Across Multiple Organ Systems and Substantial Functional Impairment
Stephanie A Richard, Simon D Pollett, Charlotte A Lanteri, et al.
Open Forum Infectious Diseases
|
January 20, 2022
Adverse Effects and Antibody Titers in Response to the BNT162b2 mRNA COVID-19 Vaccine in a Prospective Study of Healthcare Workers
Si'Ana A Coggins, Eric D Laing, Cara H Olsen, et al.
The Journal of Infectious Diseases
|
October 21, 2021
Durability of SARS-CoV-2-Specific T-Cell Responses at 12 Months Postinfection
Zhongyan Lu, Eric D Laing, Jarina Pena DaMata, et al.
BMC Infectious Diseases
|
June 10, 2021
Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workers
Belinda M Jackson-Thompson, Emilie Goguet, Eric D Laing, et al.
Emerging Infectious Diseases
|
February 24, 2022
Novel Hendra Virus Variant Detected by Sentinel Surveillance of Horses in Australia
Edward J Annand, Bethany A Horsburgh, Kai Xu, et al.
Page
of 19